Education
About Us
Working with TipRanks
Follow Us
ProtoKinetix (PKTX)
:PKTX
PKTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume47.78K
Average Volume (3M)38.95K
Market Cap
$2.45M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.63
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding389,080,140
10 Day Avg. Volume19,453
30 Day Avg. Volume38,947
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PKTX FAQ
What was ProtoKinetix’s price range in the past 12 months?
ProtoKinetix lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is ProtoKinetix’s market cap?
ProtoKinetix’s market cap is $2.45M.
When is ProtoKinetix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ProtoKinetix’s earnings last quarter?
Currently, no data Available
Is ProtoKinetix overvalued?
According to Wall Street analysts ProtoKinetix’s price is currently Overvalued.
Does ProtoKinetix pay dividends?
ProtoKinetix does not currently pay dividends.
What is ProtoKinetix’s EPS estimate?
ProtoKinetix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProtoKinetix have?
ProtoKinetix has 389,080,140 shares outstanding.
What happened to ProtoKinetix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ProtoKinetix?
Currently, no hedge funds are holding shares in PKTX
Company Description
ProtoKinetix
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.
ProtoKinetix (PKTX) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Creative Medical Technology Holdings
―
Silo Pharma
―
Spruce Biosciences
―
Longevity Health Holdings
―
Klotho Neurosciences
―
Ownership Overview
22.04% Insiders
<0.01% Other Institutional Investors
77.96% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---